Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
120 participants
OBSERVATIONAL
2024-03-27
2028-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives
Primary objective:
This project will test the hypothesis that there are two opposite brain phenotypes that characterize two distinct subpopulations of gamblers, so-called impulsive vs. emotional, respectively.
Secondary objective:
This project will also seek to determine whether the brain phenotypes proposed above are capable of predicting gambling behavior outside the laboratory.
Study design The primary objective will be tested using a reward task and a facial emotion recognition task performed by participants in an fMRI scanner.
The secondary objective will be tested by combining fMRI measures with behavioral measures from everyday life collected via Ecological Momentary Assessment (EMA).
Study population This study will focus on individuals with gambling problems, as well healthy subjects with no gambling problems and no psychiatric comorbidities.
Outcomes/Endpoints
Primary endpoint:
We will compare striatum and amygdala reactivity between the three groups of impulsive gamblers, emotional gamblers and healthy subjects.
Secondary endpoint:
We will assess the correlation between emotional states and gambling behavior in everyday life, based on striatum and amygdala reactivity, using multiple linear regression models.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Indices Associated With Relapse in Cannabis Dependence
NCT02801422
Linking fMRI to Mobile Technologies in Addiction Research: Pathophysiology of Executive Deficits, Craving and Substance Use
NCT02334956
Simultaneous Measurement of Electroencephalography (EEG) and Functional Magnetic Resonance Imaging (fMRI) in Patients With Alcoholism
NCT00216905
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
NCT00211822
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
NCT02535702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives
Primary objective:
This project will test the hypothesis that there are two opposite brain phenotypes in gambling addiction: striatal hyper-reactivity to reward combined with amygdala hypo-reactivity to emotional stimuli, and striatal hypo-reactivity to reward combined with amygdala hyper-reactivity to emotional stimuli. The investigators further hypothesize that these two brain phenotypes characterize two distinct subpopulations of gamblers, so-called impulsive vs. emotional, respectively.
Secondary objective:
This project will also seek to determine whether the brain phenotypes proposed above are capable of predicting gambling behavior outside the laboratory. To do this, the investigators will use Ecological Momentary Assessment (EMA), which involves using participants' smartphones to perform repeated, real-time sampling of their gambling behavior and emotions in real life. The investigators hypothesize that a significant difference in reactivity between the striatum and the amygdala will be associated with a strong correlation between 1) gambling behavior and positive emotions in impulsive gamblers, and 2) gambling behavior and negative emotions in emotional gamblers.
Study design The primary hypothesis will be tested using cognitive tasks performed by participants in an fMRI scanner. In order to assess striatal reactivity to reward, the investigators will use fMRI combined with a reward task. The investigators will use fMRI combined with a facial emotion recognition task to measure the reactivity of the amygdala to emotional stimuli. These tasks will allow the investigators to establish the brain phenotypes characterizing impulsive and emotional gamblers, and test the hypothesis that these phenotypes are diametrically opposed in these two sub-populations.
The secondary hypothesis will be tested by combining fMRI measures with behavioral measures from everyday life (EMA). In concrete terms, gamblers will be followed longitudinally for up to 4 weeks, and will receive short questionnaires 3 to 4 times a day on their smartphones to assess their gambling behavior (number of hours spent gambling, amount of money spent...) as well as their emotions (positive and negative). These measurements will enable the investigators to test the hypothesis that the brain phenotypes described above are capable of predicting the relationship between emotions and gambling behavior in everyday life.
Study population This study will focus on individuals with gambling problems. This category includes individuals suffering from gambling addiction as defined by the DSM-5, and individuals suffering from "problem gambling", just below the DSM-5 diagnostic threshold. Extending recruitment to individuals with problem gambling should facilitate recruitment, while considering the existence of a continuum of gambling problems.
The study will also include a control group of healthy subjects with no gambling problems and no psychiatric comorbidities.
The plan is to recruit 60 gamblers and 60 healthy controls.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals with gambling problems
This group includes individuals suffering from gambling addiction as defined by the DSM-5, and individuals suffering from "problem gambling", just below the DSM-5 diagnostic threshold.
fMRI
A brain imaging technique that measures in vivo the activity of brain areas by detecting local changes in blood flow.
Ecological Momentary Assessment
studies people's thoughts and behaviour in their daily lives by repeatedly collecting data in an individual's normal environment, at or close to the time they carry out that behaviour
Healthy control individuals
Matched healthy individuals
fMRI
A brain imaging technique that measures in vivo the activity of brain areas by detecting local changes in blood flow.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fMRI
A brain imaging technique that measures in vivo the activity of brain areas by detecting local changes in blood flow.
Ecological Momentary Assessment
studies people's thoughts and behaviour in their daily lives by repeatedly collecting data in an individual's normal environment, at or close to the time they carry out that behaviour
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 and 65
* Fluent French, read and spoken
* Male and Female
* Informed consent to take part in the research
For gamblers :
* Number of DSM-5 critera for gambling disorder ≥3
* Score ≥ 5 on the Problem Gambling Severity Index questionnaire (PGSI)
* Have a smartphone
For healthy subjects :
* no DSM-5 criteria for gambling addiction
* Score ≤ 2 on the Problem Gambling Severity Index questionnaire (PGSI)
Exclusion Criteria
* Contra-indication to MRI
* Protected Adults
* Breast feeding or pregnant women
* Neurological disorder or severe chronic illness (diabetes, heart disease, kidney disease, lung disease or liver disease, inflammatory disease….)
* Pharmacological treatment with psychotropic action (\>1 time / week)
* Regular drug use (\> 1 time/ week for at least 3 months in the last 6 months)
* Positive urine drug test on the day of the MRI sessions
For gamblers:
* Psychiatric treatment \> 1 month (pharmacological or CBT)
* Other DSM-5 diagnosis : schizophrenia, bipolar disorder, ADHD, autism, current PTSD, eating disorders, current major depressive episode, anxiety disorder, substance use disorder except nicotine, obsessive compulsive disorder.
For healthy subjects :
\- Any DSM-5 diagnosis except nicotine addiction
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Hôpital le Vinatier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume SESCOUSSE, PHD
Role: PRINCIPAL_INVESTIGATOR
CH Le Vinatier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH le Vinatier
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A00597-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.